Public Information


ACO Name and Location

Accountable Care of Northeast Florida, LLC
6520 Fort Caroline Road
Jacksonville, Florida 32277

ACO Primary Contact

Primary Contact Name Neil VillacortaBuer
Primary Contact Phone Number 904.745.3618
Primary Contact Email Address acoinfo@accountablecareofnortheastflorida.com

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Family Care Partners Of Northeast Florida Llc No

ACO governing body:

Member Member's Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Carriere William Dr. / Chair 1 ACO participant  
Patel Alpa Dr. /Participant- Arlington 1 ACO participant  
Gorospe Julius Dr. /Participant- Arlington 1 ACO participant  
Warren Randy Dr. /Participant-Fleming 1 ACO participant  
Micolucci Victor Dr. /Participant - Oceanway 1 ACO participant  
Norenberg Eric Dr. /Participant- Ponte Vedra 1 ACO participant  
Payne Pamela Medicare Beneficiary Representative 1 Medicare Beneficiary Representative  
Payne Willard Medicare Beneficiary Representative 1 Medicare Beneficiary Representative  

Key ACO clinical and administrative leadership:

William Carriere ACO Executive
Alpa Patel Medical Director
Neil VillacortaBuer Compliance Officer
Vicki-lynne Gloger Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Clinical Policy Committee Dr. Alpa Patel, MD, Chair
Quality Assurance and Improvement Committee: Dr. Julius Gorospe, MD, Chair
Performance, Finance, and Compliance Committee Dr. Charles R. Warren, DO, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2016, $0

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 76.15 80.51
ACO-2 CAHPS: How Well Your Providers Communicate 91.83 93.01
ACO-3 CAHPS: Patients’ Rating of Provider 90.88 92.25
ACO-4 CAHPS: Access to Specialists 83.94 83.49
ACO-5 CAHPS: Health Promotion and Education 63.87 60.32
ACO-6 CAHPS: Shared Decision Making 74.07 75.40
ACO-7 CAHPS: Health Status/Functional Status 71.08 72.30
ACO-34 CAHPS: Stewardship of Patient Resources 26.80 26.97
ACO-8 Risk Standardized, All Condition Readmission 14.63 14.70
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 18.58 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 45.56 53.20
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 72.06 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 56.32 59.81
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 7.98 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 16.45 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 68.97 82.72
ACO-39 Documentation of Current Medications in the Medical Record 92.85 87.54
ACO-13 Falls: Screening for Future Fall Risk 75.20 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization 61.83 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults 72.58 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 87.50 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 90.73 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 68.98 53.63
ACO-19 Colorectal Cancer Screening 57.66 61.52
ACO-20 Breast Cancer Screening 61.69 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 95.56 76.79
ACO-42 Statin therapy for the Prevention and Treatment of Cardiovascular Disease 72.98 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 14.92 18.24
ACO-41 Diabetes: Eye Exam 31.45 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 75.00 70.69
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 86.69 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 100.00 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 84.86 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for "Accountable Care of Northeast Florida, LLC" or "Accountable Care of NEFL, LLC" to view the quality performance results. This ACO can also be found by using the ACO ID A57563 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.
Download This Information (PDF)

For general questions or additional information about Accountable Care Organizations, please visit www.medicare.gov/acos.html or call 1-800-MEDICARE (1-800-633-4227) TTY users should call 1-877-486-2048